Abstract
Pediatric obsessive-compulsive disorder (OCD) is a chronic and debilitating neuropsychiatric disorder that is associated with significant psychosocial and functional impairment. This chapter reviews the literature on pediatric OCD, including clinical characteristics and etiological theories. Assessment methods, available treatment modalities (psychopharmacological and behavioral approaches), methods of treatment augmentation, and directions for future research regarding treatment dissemination are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
APA. Diagnostic and statistical manual of mental disorders (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000.
Piacentini J, Bergman RL, Keller M, McCracken J. Functional impairment in children and adolescents with obsessive-compulsive disorder. J Child Adolesc Psychopharmacol. 2003;13 Suppl 1:S61–9.
Piacentini J, Peris TS, Bergman RL, Chang S, Jaffer M. Functional impairment in childhood OCD: development and psychometrics properties of the Child Obsessive-Compulsive Impact Scale-Revised (COIS-R). J Clin Child Adolesc Psychol. 2007;36(4):645–53.
Storch EA, Ledley DR, Lewin AB, et al. Peer victimization in children with obsessive-compulsive disorder: relations with symptoms of psychopathology. J Clin Child Adolesc Psychol. 2006;35(3):446–55.
Valderhaug R, Ivarsson T. Functional impairment in clinical samples of Norwegian and Swedish children and adolescents with obsessive-compulsive disorder. Eur Child Adolesc Psychiatry. May 2005;14(3):164–73.
Lack CW, Storch EA, Keeley ML, et al. Quality of life in children and adolescents with obsessive-compulsive disorder: base rates, parent–child agreement, and clinical correlates. Soc Psychiatry Psychiatr Epidemiol. Nov 2009;44(11):935–42.
Flament MF, Koby E, Rapoport JL, et al. Childhood obsessive-compulsive disorder: a prospective follow-up study. J Child Psychol Psychiatry. Mar 1990;31(3):363–80.
Thomsen PH, Mikkelsen HU. Course of obsessive-compulsive disorder in children and adolescents: a prospective follow-up study of 23 Danish cases. J Am Acad Child Adolesc Psychiatry. 1995;34(11):1432–40.
Murray CJ, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected in 2020. Cambridge: Harvard University Press; 1996.
Bloch MH, Craiglow BG, Landeros-Weisenberger A, et al. Predictors of early adult outcomes in pediatric-onset obsessive-compulsive disorder. Pediatrics. Oct 2009;124(4):1085–93.
Lin H, Katsovich L, Ghebremichael M, et al. Psychosocial stress predicts future symptom severities in children and adolescents with Tourette syndrome and/or obsessive-compulsive disorder. J Child Psychol Psychiatry. Feb 2007;48(2):157–66.
Lafleur DL, Petty C, Mancuso E, et al. Traumatic events and obsessive compulsive disorder in children and adolescents: is there a link? J Anxiety Disord. 2011;25(4):513–9.
Storch EA, Khanna M, Merlo LJ, et al. Children’s Florida Obsessive Compulsive Inventory: psychometric properties and feasibility of a self-report measure of obsessive-compulsive symptoms in youth. Child Psychiatry Hum Dev. Sep 2009;40(3):467–83.
Storch EA, Lack C, Merlo LJ, et al. Associations between miscellaneous symptoms and symptom dimensions: an examination of pediatric obsessive-compulsive disorder. Behav Res Ther. Nov 2007;45(11):2593–603.
Swedo SE, Rapoport JL, Leonard H, Lenane M, Cheslow D. Obsessive-compulsive disorder in children and adolescents. Clinical phenomenology of 70 consecutive cases. Arch Gen Psychiatry. 1989;46(4):335–41.
Mataix-Cols D, Marks IM, Greist JH, Kobak KA, Baer L. Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial. Psychother Psychosom. 2002;71(5):255–62.
McKay D, Piacentini J, Greisberg S, Graae F, Jaffer M, Miller J. The structure of childhood obsessions and compulsions: dimensions in an outpatient sample. Behav Res Ther. Jan 2006;44(1):137–46.
Storch EA, Merlo LJ, Larson MJ, et al. Symptom dimensions and cognitive-behavioural therapy outcome for pediatric obsessive-compulsive disorder. Acta Psychiatr Scand. Jan 2008;117(1):67–75.
Coles ME, Heimberg RG, Frost RO, Steketee G. Not just right experiences and obsessive-compulsive features: experimental and self-monitoring perspectives. Behav Res Ther. Feb 2005;43(2):153–67.
Leckman JF, Walker DE, Goodman WK, Pauls DL, Cohen DJ. “Just right” perceptions associated with compulsive behavior in Tourette’s syndrome. Am J Psychiatry. May 1994;151(5):675–80.
Storch EA, Geffken GR, Merlo LJ, et al. Family accommodation in pediatric obsessive-compulsive disorder. J Clin Child Adolesc Psychol. 2007;36(2):207–16.
Peris TS, Bergman RL, Langley A, Chang S, McCracken JT, Piacentini J. Correlates of accommodation of pediatric obsessive-compulsive disorder: parent, child, and family characteristics. J Am Acad Child Adolesc Psychiatry. 2008;47(10):1173.
Lewin AB, Bergman RL, Peris TS, Chang S, McCracken JT, Piacentini J. Correlates of insight among youth with obsessive-compulsive disorder. J Child Psychol Psychiatry. 2010;51(5):603–11.
Storch EA, Milsom VA, Merlo LJ, et al. Insight in pediatric obsessive-compulsive disorder: associations with clinical presentation. Psychiatry Res. 2008;160(2):212–20.
Hollander E, Braun A, Simeon D. Should OCD leave the anxiety disorders in DSM-V? The case for obsessive compulsive-related disorders. Depress Anxiety. 2008;25(4):317–29.
Storch EA, Abramowitz J, Goodman WK. Where does obsessive-compulsive disorder belong in DSM-IV? Depress Anxiety. 2008;25:336–47.
Nestadt G, Samuels J, Riddle MA, et al. The relationship between obsessive-compulsive disorder and anxiety and affective disorders: results from the Johns Hopkins OCD Family Study. Psychol Med. Apr 2001;31(3):481–7.
Bienvenu OJ, Samuels JF, Riddle MA, et al. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry. 2000;48(4):287–93.
Richter MA, Summerfeldt LJ, Antony MM, Swinson RP. Obsessive-compulsive spectrum conditions in obsessive-compulsive disorder and other anxiety disorders. Depress Anxiety. 2003;18(3):118–27.
Mataix-Cols D, Frost RO, Pertusa A, et al. Hoarding disorder: a new diagnosis for DSM-V? Depress Anxiety. Jun 2010;27(6):556–72.
Samuels JF, Bienvenu OJ, Grados MA, et al. Prevalence and correlates of hoarding behavior in a community-based sample. Behav Res Ther. Jul 2008;46(7):836–44.
Olatunji BO, Williams BJ, Haslam N, Abramowitz JS, Tolin DF. The latent structure of obsessive-compulsive symptoms: a taxometric study. Depress Anxiety. 2008;25(11):956–68.
Abramowitz JS, Wheaton MG, Storch EA. The status of hoarding as a symptom of obsessive-compulsive disorder. Behav Res Ther. Sep 2008;46(9):1026–33.
Pertusa A, Frost RO, Fullana MA, et al. Refining the diagnostic boundaries of compulsive hoarding: a critical review. Clin Psychol Rev. Jun 2010;30(4):371–86.
Mataix-Cols D, Rauch SL, Manzo PA, Jenike MA, Baer L. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry. Sep 1999;156(9):1409–16.
Winsberg ME, Cassic KS, Koran LM. Hoarding in obsessive-compulsive disorder: a report of 20 cases. J Clin Psychiatry. Sep 1999;60(9):591–7.
Lochner C, Kinnear CJ, Hemmings SM, et al. Hoarding in obsessive-compulsive disorder: clinical and genetic correlates. J Clin Psychiatry. Sep 2005;66(9):1155–60.
Saxena S, Brody AL, Maidment KM, et al. Cerebral glucose metabolism in obsessive-compulsive hoarding. Am J Psychiatry. Jun 2004;161(6):1038–48.
Saxena S. Neurobiology and treatment of compulsive hoarding. CNS Spectr. Sep 2008;13(9 Suppl 14):29–36.
Rapoport JL, Inoff-Germain G, Weissman MM, et al. Childhood obsessive-compulsive disorder in the NIMH MECA study: parent versus child identification of cases. Methods for the epidemiology of child and adolescent mental disorders. J Anxiety Disord. 2000;14(6):535–48.
Zohar AH. The epidemiology of obsessive-compulsive disorder in children and adolescents. Child Adolesc Psychiatr Clin N Am. Jul 1999;8(3):445–60.
Delorme R, Golmard JL, Chabane N, et al. Admixture analysis of age at onset in obsessive-compulsive disorder. Psychol Med. Feb 2005;35(2):237–43.
Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. Jan 2010;15(1):53–63.
Castle DJ, Deale A, Marks IM. Gender differences in obsessive compulsive disorder. Aust N Z J Psychiatry. Mar 1995;29(1):114–7.
Chabane N, Delorme R, Millet B, Mouren MC, Leboyer M, Pauls D. Early-onset obsessive-compulsive disorder: a subgroup with a specific clinical and familial pattern? J Child Psychol Psychiatry. Aug 2005;46(8):881–7.
Nestadt G, Samuels J, Riddle M, et al. A family study of obsessive-compulsive disorder. Arch Gen Psychiatry. 2000;57(4):358–63.
Stewart SE, Geller DA, Jenike M, et al. Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature. Acta Psychiatr Scand. 2004;110(1):4–13.
Geller DA, Biederman J, Griffin S, Jones J, Lefkowitz TR. Comorbidity of juvenile obsessive-compulsive disorder with disruptive behavior disorders. J Am Acad Child Adolesc Psychiatry. 1996;35(12):1637–46.
Riddle MA, Scahill L, King R, et al. Obsessive compulsive disorder in children and adolescents: phenomenology and family history. J Am Acad Child Adolesc Psychiatry. 1990;29(5):766–72.
Hanna GL, Yuwiler A, Coates JK. Whole blood serotonin and disruptive behaviors in juvenile obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 1995;34(1):28–35.
Storch EA, Larson MJ, Keely ML, Geffken GR, Murphy TK, Goodman W. Comorbidity of pediatric obsessive-compulsive disorder and anxiety disorders: Impact on symptom severity and impairment. J Psychopathol Behav Assess. 2008;30(2):111–20.
Geller DA, Biederman J, Faraone SV, et al. Clinical correlates of obsessive compulsive disorder in children and adolescents referred to specialized and non-specialized clinical settings. Depress Anxiety. 2000;11(4):163–8.
Masi G, Perugi G, Millepiedi S, et al. Bipolar co-morbidity in pediatric obsessive-compulsive disorder: clinical and treatment implications. J Child Adolesc Psychopharmacol. Aug 2007;17(4):475–86.
POTS. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA. 2004;292(16):1969–76.
March JS, Franklin ME, Leonard H, et al. Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry. 2007;61(3):344–7.
Geller DA, Biederman J, Stewart SE, et al. Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials? J Child Adolesc Psychopharmacol. 2003;13 Suppl 1:S19–29.
Storch EA, Merlo LJ, Larson MJ, et al. Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2008;47(5):583–92.
Abramowitz JS, Foa EB. Worries and obsessions in individuals with obsessive-compulsive disorder with and without comorbid generalized anxiety disorder. Behav Res Ther. 1998;36(7–8):695–700.
Turner SM, Beidel DC, Stanley MA. Are obsessional thoughts and worry different cognitive phenomena? Clin Psychol Rev. 1992;12:257–70.
Taylor S, Thoardarson DS, Sochting I. Obsessive-compulsive disorder. In: Antony MM, Barlow DH, editors. Handbook of assessment and treatment planning for psychological disorders. New York: Guildford Press; 2002. p. 182–214.
Mansueto CS, Keuler DJ. Tic or compulsion?: It’s Tourettic OCD. Behav Modif. Sep 2005;29(5):784–99.
Castellanos FX. Tic disorders and obsessive-compulsive disorder. In: Cohen DJ, Bruun RD, Leckman JF, editors. Child psychopharmacology. New York: Wiley; 1998.
Leckman JF, Walker DE, Cohen DJ. Premonitory urges in Tourette’s syndrome. Am J Psychiatry. Jan 1993;150(1):98–102.
Jimenez-Murcia S, Fernandez-Aranda F, Raich RM, et al. Obsessive-compulsive and eating disorders: comparison of clinical and personality features. Psychiatry Clin Neurosci. Aug 2007;61(4):385–91.
Strober M, Freeman R, Lampert C, Diamond J. The association of anxiety disorders and obsessive compulsive personality disorder with anorexia nervosa: evidence from a family study with discussion of nosological and neurodevelopmental implications. Int J Eat Disord. 2007;40 Suppl 3:S46–51.
Lewin AB, Menzel J, Strober M. Assessment and treatment of comorbid anorexia nervosa and obsessive compulsive disorder. In: Storch EA, Mckay D, editors. Handbook of treating variants and complications in anxiety disorders; 2013 (in press).
Lewin AB, Wood JJ, Gunderson S, Murphy TK, Storch EA. Obsessive compulsive symptoms in youth with high functioning autism spectrum disorders. J Dev Phys Disabil. 2011;23:543–53.
Ivarsson T, Melin K. Autism spectrum traits in children and adolescents with obsessive-compulsive disorder (OCD). J Anxiety Disord. Aug 2008;22(6):969–78.
Rapp JT, Vollmer TR. Stereotypy I: a review of behavioral assessment and treatment. Res Dev Disabil. 2005;26(6):527–47.
Saxena S, Brody AL, Schwartz JM, Baxter LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl. 1998;35:26–37.
Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci. 1986;9:357–81.
Rosenberg DR, Keshavan MS. A.E. Bennett Research Award. Toward a neurodevelopmental model of obsessive–compulsive disorder. Biol Psychiatry. 1998;43(9):623–40.
Rapoport JL, Wise SP. Obsessive-compulsive disorder: evidence for basal ganglia dysfunction. Psychopharmacol Bull. 1988;24(3):380–4.
Baxter Jr LR, Schwartz JM, Bergman KS, et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry. Sep 1992;49(9):681–9.
Rauch SL, Baxter LR. Neuroimaging in obsessive-compulsive disorder and related disorders. In: Jenike MA, Baer L, Minichiello WE, editors. Obsessive-compulsive disorders: practical management, vol. 3. St. Louis, MO: Mosby; 1998. p. 289–317.
Saxena S, Bota RG, Brody AL. Brain-behavior relationships in obsessive-compulsive disorder. Semin Clin Neuropsychiatry. 2001;6(2):82–101.
Kim JJ, Lee MC, Kim J, et al. Grey matter abnormalities in obsessive-compulsive disorder: statistical parametric mapping of segmented magnetic resonance images. Br J Psychiatry. Oct 2001;179:330–4.
MacMaster FP, O’Neill J, Rosenberg DR. Brain imaging in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. Nov 2008;47(11):1262–72.
Arnold PD, Macmaster FP, Richter MA, et al. Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive-compulsive disorder. Psychiatry Res. 2009;172(2):136–9.
Friedlander L, Desrocher M. Neuroimaging studies of obsessive-compulsive disorder in adults and children. Clin Psychol Rev. 2006;26:32–49.
Woolley J, Heyman I, Brammer M, Frampton I, McGuire PK, Rubia K. Brain activation in paediatric obsessive compulsive disorder during tasks of inhibitory control. Br J Psychiatry. 2008;192:25–31.
Iversen SD, Mishkin M. Perseverative interference in monkeys following selective lesions of the inferior prefrontal convexity. Exp Brain Res. 1970;11(4):376–86.
Szeszko PR, MacMillan S, McMeniman M, et al. Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder. Am J Psychiatry. 2004;161(6):1049–56.
Gilbert AR, Moore GJ, Keshavan MS, et al. Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine. Arch Gen Psychiatry. 2000;57(5):449–56.
Szeszko PR, MacMillan S, McMeniman M, et al. Amygdala volume reductions in pediatric patients with obsessive-compulsive disorder treated with paroxetine: preliminary findings. Neuropsychopharmacology. 2004;29(4):826–32.
Barr LC, Goodman WK, Price LH, McDougle CJ, Charney DS. The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies. J Clin Psychiatry. Apr 1992;53(Suppl):17–28.
Goodman WK, McDougle CJ, Price LH, Riddle MA, Pauls DL, Leckman JF. Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? J Clin Psychiatry. 1990;51(Suppl):36–43. discussion 55–38.
Rosenberg DR, Mirza Y, Russell A, et al. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. J Am Acad Child Adolesc Psychiatry. Sep 2004;43(9):1146–53.
Grant P, Lougee L, Hirschtritt M, Swedo SE. An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive-compulsive disorder. J Child Adolesc Psychopharmacol. Dec 2007;17(6):761–7.
Denys D, van der Wee N, Janssen J, De Geus F, Westenberg HG. Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder. Biol Psychiatry. 2004;55(10):1041–5.
van der Wee NJ, Stevens H, Hardeman JA, et al. Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [123I]{beta}-CIT SPECT. Am J Psychiatry. Dec 2004;161(12):2201–6.
Denys D, de Geus F, van Megen HJ, Westenberg HG. A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors. J Clin Psychiatry. 2004;65(8):1040–8.
Mowrer OH. A stimulus–response analysis of anxiety and its role as a reinforcing agent. Psychol Rev. 1939;46:553–65.
Mowrer OH. Learning theory and behavior. New York: John Wiley; 1960.
Franklin ME, Foa EB. Cognitive behavioral treatments for obsessive compulsive disorder. In: Nathan PE, Gorman JM, editors. A guide to treatments that work, vol. 2. 386: Oxford University Press; 2002. p. 367.
Salkovskis PM. Understanding and treating obsessive-compulsive disorder. Behav Res Ther. 1999;37 Suppl 1:S29–52.
Salkovskis PM. Obsessional-compulsive problems: a cognitive-behavioural analysis. Behav Res Ther. 1985;23(5):571–83.
AACAP. Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2012;51(1):98–113.
Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. Feb 1998;155(2):264–71.
Murphy TK, Kurlan R, Leckman J. The immunobiology of Tourette’s disorder, pediatric autoimmune neuropsychiatric disorders associated with Streptococcus, and related disorders: a way forward. J Child Adolesc Psychopharmacol. Aug 2010;20(4):317–31.
Murphy TK, Sajid M, Soto O, et al. Detecting pediatric autoimmune neuropsychiatric disorders associated with streptococcus in children with obsessive-compulsive disorder and tics. Biol Psychiatry. 2004;55(1):61–8.
Leonard HL, Swedo SE. Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS). Int J Neuropsychopharmacol. 2001;4(2):191–8.
Jenike MA. Obsessive-compulsive and related disorders: a hidden epidemic. N Eng J Med. 1989;321(8):539–41.
Lewin AB, Piacentini J. Evidence-based assessment of child Obsessive Compulsive Disorder: recommendations for clinical practice and treatment research. Child Youth Care Forum. Apr 2010;39(2):73–89.
Scahill L, Riddle MA, McSwiggin-Hardin M, et al. Children’s Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry. Jun 1997;36(6):844–52.
Calvocoressi L, Mazure CM, Kasl SV, et al. Family accommodation of obsessive-compulsive symptoms: instrument development and assessment of family behavior. J Nerv Ment Dis. 1999;187(10):636–42.
Foa EB, Coles M, Huppert JD, Pasupuleti RV, Franklin ME, March J. Development and validation of a child version of the obsessive compulsive inventory. Behav Ther. Mar 2010;41(1):121–32.
Shafran R, Frampton I, Heyman I, Reynolds M, Teachman B, Rachman S. The preliminary development of a new self-report measure for OCD in young people. J Adolesc. Feb 2003;26(1):137–42.
Biederman J. Sudden death in children treated with a tricyclic antidepressant. J Am Acad Child Adolesc Psychiatry. May 1991;30(3):495–8.
Piacentini J, Bergman RL, Chang S, et al. Controlled comparison of family cognitive behavioral therapy and psychoeducation/relaxation training for child obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. Nov 2011;50(11):1149–61.
Geller DA, Hoog SL, Heiligenstein JH, et al. Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial. J Am Acad Child Adolesc Psychiatry. 2001;40(7):773–9.
Barrett P, Healy-Farrell L, March JS. Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial. J Am Acad Child Adolesc Psychiatry. 2004;43(1):46–62.
Storch EA, Geffken GR, Merlo LJ, et al. Family-based cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: comparison of intensive and weekly approaches. J Am Acad Child Adolesc Psychiatry. 2007;46(4):469–78.
Liebowitz MR, Turner SM, Piacentini J, et al. Fluoxetine in children and adolescents with OCD: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2002;41(12):1431–8.
Riddle MA, Reeve EA, Yaryura-Tobias JA, et al. Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial. J Am Acad Child Adolesc Psychiatry. Feb 2001;40(2):222–9.
de Haan E, Hoogduin KA, Buitelaar JK, Keijsers GP. Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1998;37(10):1022–9.
Flament MF, Rapoport JL, Berg CJ, et al. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study. Arch Gen Psychiatry. 1985;42(10):977–83.
DeVeaugh-Geiss J, Moroz G, Biederman J, et al. Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder—a multicenter trial. J Am Acad Child Adolesc Psychiatry. Jan 1992;31(1):45–9.
Asbahr FR, Castillo AR, Ito LM, Latorre MR, Moreira MN, Lotufo-Neto F. Group cognitive-behavioral therapy versus sertraline for the treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. Nov 2005;44(11):1128–36.
Geller DA, Biederman J, Stewart SE, et al. Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry. Nov 2003;160(11):1919–28.
March JS, Biederman J, Wolkow R, et al. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. JAMA. 1998;280(20):1752–6.
Geller DA, Wagner KD, Emslie G, et al. Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2004;43(11):1387–96.
Mukaddes NM, Abali O, Kaynak N. Citalopram treatment of children and adolescents with obsessive-compulsive disorder: a preliminary report. Psychiatry Clin Neurosci. Aug 2003;57(4):405–8.
Goodman WK, Murphy TK, Storch EA. Risk of adverse behavioral effects with pediatric use of antidepressants. Psychopharmacology (Berl). Mar 2007;191(1):87–96.
Carlson GA. Early onset bipolar disorder: clinical and research considerations. J Clin Child Adolesc Psychol. Jun 2005;34(2):333–43.
Guile JM. Sertraline-induced behavioral activation during the treatment of an adolescent with major depression. J Child Adolesc Psychopharmacol. Winter 1996;6(4):281–5.
Riddle MA, King RA, Hardin MT, Scahill L, Ort SI, Leckman JF. Behavioral side effects of fluoxetine in children and adolescents. J Child Adolesc Psychopharmacol. 1991;1:193–8.
Safer DJ, Zito JM. Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescents. J Child Adolesc Psychopharmacol. 2006;16(1–2):159–69.
Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA. 2007;297(15):1683–96.
Thomsen PH. Risperidone augmentation in the treatment of severe adolescent OCD in SSRI-refractory cases: a case-series. Ann Clin Psychiatry. 2004;16:201–7.
Masi G, Pfanner C, Millepiedi S, Berloffa S. Aripiprazole augmentation in 39 adolescents with medication-resistant obsessive-compulsive disorder. J Clin Psychopharmacol. Dec 2010;30(6):688–93.
Lewin AB, Storch EA, Storch HD. Risks from antipsychotic medications in children and adolescents. JAMA. 2010;303(8):729–30.
Storch EA, Bjorgvinsson T, Riemann B, Lewin AB, Morales MJ, Murphy TK. Factors associated with poor response in cognitive-behavioral therapy for pediatric obsessive-compulsive disorder. Bull Menninger Clin. Spring 2010;74(2):167–85.
Lewin AB, Peris TS, Lindsey Bergman R, McCracken JT, Piacentini J. The role of treatment expectancy in youth receiving exposure-based CBT for obsessive compulsive disorder. Behav Res Ther. Sep 2011;49(9):536–43.
Piacentini J, Langley A, Roblek T. Overcoming childhood OCD: a therapist’s guide. New York: Oxford University Press; 2007.
Freeman JB, Garcia AM, Coyne L, et al. Early childhood OCD: preliminary findings from a family-based cognitive-behavioral approach. J Am Acad Child Adolesc Psychiatry. May 2008;47(5):593–602.
Watson HJ, Rees CS. Meta-analysis of randomized, controlled treatment trials for pediatric obsessive-compulsive disorder. J Child Psychol Psychiatry. May 2008;49(5):489–98.
Franklin ME, Sapyta J, Freeman JB, et al. Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial. JAMA. 2011;306(11):1224–32.
Lewin AB, Piacentini J. Obsessive-compulsive disorder in children. In: Sadock BJ, Sadock VA, Ruiz P, editors. Kaplan & Sadock’s comprehensive textbook of psychiatry, vol. 2. 9th ed. Philadelphia: Lippincott, Williams & Wilkins; 2009. p. 3671–8.
Barrett PM, Farrell L, Pina AA, Peris TS, Piacentini J. Evidence-based psychosocial treatments for child and adolescent obsessive-compulsive disorder. J Clin Child Adolesc Psychol. 2008;37(1):131–55.
Snider LA, Lougee L, Slattery M, Grant P, Swedo SE. Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry. 2005;57(7):788–92.
Garvey MA, Perlmutter SJ, Allen AJ, et al. A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry. 1999;45(12):1564–71.
Storch EA, Murphy TK, Geffken GR, et al. Cognitive-behavioral therapy for PANDAS-related obsessive-compulsive disorder: findings from a preliminary waitlist controlled open trial. J Am Acad Child Adolesc Psychiatry. Oct 2006;45(10):1171–8.
Walker DL, Ressler KJ, Lu KT, Davis M. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of d-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci. 2002;22(6):2343–51.
Ledgerwood L, Richardson R, Cranney J. d-Cycloserine and the facilitation of extinction of conditioned fear: consequences for reinstatement. Behav Neurosci. Jun 2004;118(3):505–13.
Ledgerwood L, Richardson R, Cranney J. Effects of d-cycloserine on extinction of conditioned freezing. Behav Neurosci. Apr 2003;117(2):341–9.
Storch EA, Murphy TK, Goodman WK, et al. A preliminary study of d-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry. 2010;68(11):1073–6.
Storch EA, Caporino NE, Morgan JR, et al. Preliminary investigation of web-camera delivered cognitive-behavioral therapy for youth with obsessive-compulsive disorder. Psychiatry Res. 2011;189(3):407–12.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Lewin, A.B., Park, J.M., Storch, E.A. (2013). Obsessive-Compulsive Disorder in Children and Adolescents. In: Vasa, R., Roy, A. (eds) Pediatric Anxiety Disorders. Current Clinical Psychiatry. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4614-6599-7_9
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6599-7_9
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4614-6598-0
Online ISBN: 978-1-4614-6599-7
eBook Packages: MedicineMedicine (R0)